- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
The Parkinson's Disease Treatments market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Parkinson's Disease Treatments market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospitals accounting for % of the Parkinson's Disease Treatments global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Dopamine Agonists segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Parkinson's Disease Treatments include GSK, Merck, Novartis, Teva, and Boehringer Ingelheim, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Parkinson's Disease Treatments market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Dopamine Agonists
Levodopa
Glutamate Antagonist
Apomorphine
COMT Inhibitors Anticholinergics
MAO-B Inhibitors
Other Drugs
Market segment by Application, can be divided into
Hospitals
Healthcare Institutes
Others
Market segment by players, this report covers
GSK
Merck
Novartis
Teva
Boehringer Ingelheim
Impax
Abbvie
Bausch Health
Lundbeck
Sun Pharma
Wockhardt
Acadia
UCB
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Parkinson's Disease Treatments product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Parkinson's Disease Treatments, with revenue, gross margin and global market share of Parkinson's Disease Treatments from 2019 to 2022.
Chapter 3, the Parkinson's Disease Treatments competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Parkinson's Disease Treatments market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Parkinson's Disease Treatments research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Parkinson's Disease Treatments
1.2 Classification of Parkinson's Disease Treatments by Type
1.2.1 Overview: Global Parkinson's Disease Treatments Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Parkinson's Disease Treatments Revenue Market Share by Type in 2021
1.2.3 Dopamine Agonists
1.2.4 Levodopa
1.2.5 Glutamate Antagonist
1.2.6 Apomorphine
1.2.7 COMT Inhibitors Anticholinergics
1.2.8 MAO-B Inhibitors
1.2.9 Other Drugs
1.3 Global Parkinson's Disease Treatments Market by Application
1.3.1 Overview: Global Parkinson's Disease Treatments Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospitals
1.3.3 Healthcare Institutes
1.3.4 Others
1.4 Global Parkinson's Disease Treatments Market Size & Forecast
1.5 Global Parkinson's Disease Treatments Market Size and Forecast by Region
1.5.1 Global Parkinson's Disease Treatments Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Parkinson's Disease Treatments Market Size by Region, (2017-2022)
1.5.3 North America Parkinson's Disease Treatments Market Size and Prospect (2017-2028)
1.5.4 Europe Parkinson's Disease Treatments Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Parkinson's Disease Treatments Market Size and Prospect (2017-2028)
1.5.6 South America Parkinson's Disease Treatments Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Parkinson's Disease Treatments Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Parkinson's Disease Treatments Market Drivers
1.6.2 Parkinson's Disease Treatments Market Restraints
1.6.3 Parkinson's Disease Treatments Trends Analysis
2 Company Profiles
2.1 GSK
2.1.1 GSK Details
2.1.2 GSK Major Business
2.1.3 GSK Parkinson's Disease Treatments Product and Solutions
2.1.4 GSK Parkinson's Disease Treatments Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 GSK Recent Developments and Future Plans
2.2 Merck
2.2.1 Merck Details
2.2.2 Merck Major Business
2.2.3 Merck Parkinson's Disease Treatments Product and Solutions
2.2.4 Merck Parkinson's Disease Treatments Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Merck Recent Developments and Future Plans
2.3 Novartis
2.3.1 Novartis Details
2.3.2 Novartis Major Business
2.3.3 Novartis Parkinson's Disease Treatments Product and Solutions
2.3.4 Novartis Parkinson's Disease Treatments Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Novartis Recent Developments and Future Plans
2.4 Teva
2.4.1 Teva Details
2.4.2 Teva Major Business
2.4.3 Teva Parkinson's Disease Treatments Product and Solutions
2.4.4 Teva Parkinson's Disease Treatments Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Teva Recent Developments and Future Plans
2.5 Boehringer Ingelheim
2.5.1 Boehringer Ingelheim Details
2.5.2 Boehringer Ingelheim Major Business
2.5.3 Boehringer Ingelheim Parkinson's Disease Treatments Product and Solutions
2.5.4 Boehringer Ingelheim Parkinson's Disease Treatments Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Boehringer Ingelheim Recent Developments and Future Plans
2.6 Impax
2.6.1 Impax Details
2.6.2 Impax Major Business
2.6.3 Impax Parkinson's Disease Treatments Product and Solutions
2.6.4 Impax Parkinson's Disease Treatments Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Impax Recent Developments and Future Plans
2.7 Abbvie
2.7.1 Abbvie Details
2.7.2 Abbvie Major Business
2.7.3 Abbvie Parkinson's Disease Treatments Product and Solutions
2.7.4 Abbvie Parkinson's Disease Treatments Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Abbvie Recent Developments and Future Plans
2.8 Bausch Health
2.8.1 Bausch Health Details
2.8.2 Bausch Health Major Business
2.8.3 Bausch Health Parkinson's Disease Treatments Product and Solutions
2.8.4 Bausch Health Parkinson's Disease Treatments Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 Bausch Health Recent Developments and Future Plans
2.9 Lundbeck
2.9.1 Lundbeck Details
2.9.2 Lundbeck Major Business
2.9.3 Lundbeck Parkinson's Disease Treatments Product and Solutions
2.9.4 Lundbeck Parkinson's Disease Treatments Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 Lundbeck Recent Developments and Future Plans
2.10 Sun Pharma
2.10.1 Sun Pharma Details
2.10.2 Sun Pharma Major Business
2.10.3 Sun Pharma Parkinson's Disease Treatments Product and Solutions
2.10.4 Sun Pharma Parkinson's Disease Treatments Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 Sun Pharma Recent Developments and Future Plans
2.11 Wockhardt
2.11.1 Wockhardt Details
2.11.2 Wockhardt Major Business
2.11.3 Wockhardt Parkinson's Disease Treatments Product and Solutions
2.11.4 Wockhardt Parkinson's Disease Treatments Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11.5 Wockhardt Recent Developments and Future Plans
2.12 Acadia
2.12.1 Acadia Details
2.12.2 Acadia Major Business
2.12.3 Acadia Parkinson's Disease Treatments Product and Solutions
2.12.4 Acadia Parkinson's Disease Treatments Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12.5 Acadia Recent Developments and Future Plans
2.13 UCB
2.13.1 UCB Details
2.13.2 UCB Major Business
2.13.3 UCB Parkinson's Disease Treatments Product and Solutions
2.13.4 UCB Parkinson's Disease Treatments Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13.5 UCB Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Parkinson's Disease Treatments Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Parkinson's Disease Treatments Players Market Share in 2021
3.2.2 Top 10 Parkinson's Disease Treatments Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Parkinson's Disease Treatments Players Head Office, Products and Services Provided
3.4 Parkinson's Disease Treatments Mergers & Acquisitions
3.5 Parkinson's Disease Treatments New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Parkinson's Disease Treatments Revenue and Market Share by Type (2017-2022)
4.2 Global Parkinson's Disease Treatments Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5.1 Global Parkinson's Disease Treatments Revenue Market Share by Application (2017-2022)
5.2 Global Parkinson's Disease Treatments Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6.1 North America Parkinson's Disease Treatments Revenue by Type (2017-2028)
6.2 North America Parkinson's Disease Treatments Revenue by Application (2017-2028)
6.3 North America Parkinson's Disease Treatments Market Size by Country
6.3.1 North America Parkinson's Disease Treatments Revenue by Country (2017-2028)
6.3.2 United States Parkinson's Disease Treatments Market Size and Forecast (2017-2028)
6.3.3 Canada Parkinson's Disease Treatments Market Size and Forecast (2017-2028)
6.3.4 Mexico Parkinson's Disease Treatments Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7.1 Europe Parkinson's Disease Treatments Revenue by Type (2017-2028)
7.2 Europe Parkinson's Disease Treatments Revenue by Application (2017-2028)
7.3 Europe Parkinson's Disease Treatments Market Size by Country
7.3.1 Europe Parkinson's Disease Treatments Revenue by Country (2017-2028)
7.3.2 Germany Parkinson's Disease Treatments Market Size and Forecast (2017-2028)
7.3.3 France Parkinson's Disease Treatments Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Parkinson's Disease Treatments Market Size and Forecast (2017-2028)
7.3.5 Russia Parkinson's Disease Treatments Market Size and Forecast (2017-2028)
7.3.6 Italy Parkinson's Disease Treatments Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Parkinson's Disease Treatments Revenue by Type (2017-2028)
8.2 Asia-Pacific Parkinson's Disease Treatments Revenue by Application (2017-2028)
8.3 Asia-Pacific Parkinson's Disease Treatments Market Size by Region
8.3.1 Asia-Pacific Parkinson's Disease Treatments Revenue by Region (2017-2028)
8.3.2 China Parkinson's Disease Treatments Market Size and Forecast (2017-2028)
8.3.3 Japan Parkinson's Disease Treatments Market Size and Forecast (2017-2028)
8.3.4 South Korea Parkinson's Disease Treatments Market Size and Forecast (2017-2028)
8.3.5 India Parkinson's Disease Treatments Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Parkinson's Disease Treatments Market Size and Forecast (2017-2028)
8.3.7 Australia Parkinson's Disease Treatments Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9.1 South America Parkinson's Disease Treatments Revenue by Type (2017-2028)
9.2 South America Parkinson's Disease Treatments Revenue by Application (2017-2028)
9.3 South America Parkinson's Disease Treatments Market Size by Country
9.3.1 South America Parkinson's Disease Treatments Revenue by Country (2017-2028)
9.3.2 Brazil Parkinson's Disease Treatments Market Size and Forecast (2017-2028)
9.3.3 Argentina Parkinson's Disease Treatments Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Parkinson's Disease Treatments Revenue by Type (2017-2028)
10.2 Middle East & Africa Parkinson's Disease Treatments Revenue by Application (2017-2028)
10.3 Middle East & Africa Parkinson's Disease Treatments Market Size by Country
10.3.1 Middle East & Africa Parkinson's Disease Treatments Revenue by Country (2017-2028)
10.3.2 Turkey Parkinson's Disease Treatments Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Parkinson's Disease Treatments Market Size and Forecast (2017-2028)
10.3.4 UAE Parkinson's Disease Treatments Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of Tables
Table 1. Global Parkinson's Disease Treatments Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Parkinson's Disease Treatments Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Parkinson's Disease Treatments Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Parkinson's Disease Treatments Revenue (USD Million) by Region (2017-2022)
Table 5. Global Parkinson's Disease Treatments Revenue Market Share by Region (2023-2028)
Table 6. GSK Corporate Information, Head Office, and Major Competitors
Table 7. GSK Major Business
Table 8. GSK Parkinson's Disease Treatments Product and Solutions
Table 9. GSK Parkinson's Disease Treatments Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Merck Corporate Information, Head Office, and Major Competitors
Table 11. Merck Major Business
Table 12. Merck Parkinson's Disease Treatments Product and Solutions
Table 13. Merck Parkinson's Disease Treatments Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Novartis Corporate Information, Head Office, and Major Competitors
Table 15. Novartis Major Business
Table 16. Novartis Parkinson's Disease Treatments Product and Solutions
Table 17. Novartis Parkinson's Disease Treatments Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Teva Corporate Information, Head Office, and Major Competitors
Table 19. Teva Major Business
Table 20. Teva Parkinson's Disease Treatments Product and Solutions
Table 21. Teva Parkinson's Disease Treatments Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Boehringer Ingelheim Corporate Information, Head Office, and Major Competitors
Table 23. Boehringer Ingelheim Major Business
Table 24. Boehringer Ingelheim Parkinson's Disease Treatments Product and Solutions
Table 25. Boehringer Ingelheim Parkinson's Disease Treatments Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Impax Corporate Information, Head Office, and Major Competitors
Table 27. Impax Major Business
Table 28. Impax Parkinson's Disease Treatments Product and Solutions
Table 29. Impax Parkinson's Disease Treatments Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Abbvie Corporate Information, Head Office, and Major Competitors
Table 31. Abbvie Major Business
Table 32. Abbvie Parkinson's Disease Treatments Product and Solutions
Table 33. Abbvie Parkinson's Disease Treatments Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Bausch Health Corporate Information, Head Office, and Major Competitors
Table 35. Bausch Health Major Business
Table 36. Bausch Health Parkinson's Disease Treatments Product and Solutions
Table 37. Bausch Health Parkinson's Disease Treatments Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Lundbeck Corporate Information, Head Office, and Major Competitors
Table 39. Lundbeck Major Business
Table 40. Lundbeck Parkinson's Disease Treatments Product and Solutions
Table 41. Lundbeck Parkinson's Disease Treatments Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. Sun Pharma Corporate Information, Head Office, and Major Competitors
Table 43. Sun Pharma Major Business
Table 44. Sun Pharma Parkinson's Disease Treatments Product and Solutions
Table 45. Sun Pharma Parkinson's Disease Treatments Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. Wockhardt Corporate Information, Head Office, and Major Competitors
Table 47. Wockhardt Major Business
Table 48. Wockhardt Parkinson's Disease Treatments Product and Solutions
Table 49. Wockhardt Parkinson's Disease Treatments Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 50. Acadia Corporate Information, Head Office, and Major Competitors
Table 51. Acadia Major Business
Table 52. Acadia Parkinson's Disease Treatments Product and Solutions
Table 53. Acadia Parkinson's Disease Treatments Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 54. UCB Corporate Information, Head Office, and Major Competitors
Table 55. UCB Major Business
Table 56. UCB Parkinson's Disease Treatments Product and Solutions
Table 57. UCB Parkinson's Disease Treatments Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 58. Global Parkinson's Disease Treatments Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 59. Global Parkinson's Disease Treatments Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 60. Breakdown of Parkinson's Disease Treatments by Company Type (Tier 1, Tier 2 and Tier 3)
Table 61. Parkinson's Disease Treatments Players Head Office, Products and Services Provided
Table 62. Parkinson's Disease Treatments Mergers & Acquisitions in the Past Five Years
Table 63. Parkinson's Disease Treatments New Entrants and Expansion Plans
Table 64. Global Parkinson's Disease Treatments Revenue (USD Million) by Type (2017-2022)
Table 65. Global Parkinson's Disease Treatments Revenue Share by Type (2017-2022)
Table 66. Global Parkinson's Disease Treatments Revenue Forecast by Type (2023-2028)
Table 67. Global Parkinson's Disease Treatments Revenue by Application (2017-2022)
Table 68. Global Parkinson's Disease Treatments Revenue Forecast by Application (2023-2028)
Table 69. North America Parkinson's Disease Treatments Revenue by Type (2017-2022) & (USD Million)
Table 70. North America Parkinson's Disease Treatments Revenue by Type (2023-2028) & (USD Million)
Table 71. North America Parkinson's Disease Treatments Revenue by Application (2017-2022) & (USD Million)
Table 72. North America Parkinson's Disease Treatments Revenue by Application (2023-2028) & (USD Million)
Table 73. North America Parkinson's Disease Treatments Revenue by Country (2017-2022) & (USD Million)
Table 74. North America Parkinson's Disease Treatments Revenue by Country (2023-2028) & (USD Million)
Table 75. Europe Parkinson's Disease Treatments Revenue by Type (2017-2022) & (USD Million)
Table 76. Europe Parkinson's Disease Treatments Revenue by Type (2023-2028) & (USD Million)
Table 77. Europe Parkinson's Disease Treatments Revenue by Application (2017-2022) & (USD Million)
Table 78. Europe Parkinson's Disease Treatments Revenue by Application (2023-2028) & (USD Million)
Table 79. Europe Parkinson's Disease Treatments Revenue by Country (2017-2022) & (USD Million)
Table 80. Europe Parkinson's Disease Treatments Revenue by Country (2023-2028) & (USD Million)
Table 81. Asia-Pacific Parkinson's Disease Treatments Revenue by Type (2017-2022) & (USD Million)
Table 82. Asia-Pacific Parkinson's Disease Treatments Revenue by Type (2023-2028) & (USD Million)
Table 83. Asia-Pacific Parkinson's Disease Treatments Revenue by Application (2017-2022) & (USD Million)
Table 84. Asia-Pacific Parkinson's Disease Treatments Revenue by Application (2023-2028) & (USD Million)
Table 85. Asia-Pacific Parkinson's Disease Treatments Revenue by Region (2017-2022) & (USD Million)
Table 86. Asia-Pacific Parkinson's Disease Treatments Revenue by Region (2023-2028) & (USD Million)
Table 87. South America Parkinson's Disease Treatments Revenue by Type (2017-2022) & (USD Million)
Table 88. South America Parkinson's Disease Treatments Revenue by Type (2023-2028) & (USD Million)
Table 89. South America Parkinson's Disease Treatments Revenue by Application (2017-2022) & (USD Million)
Table 90. South America Parkinson's Disease Treatments Revenue by Application (2023-2028) & (USD Million)
Table 91. South America Parkinson's Disease Treatments Revenue by Country (2017-2022) & (USD Million)
Table 92. South America Parkinson's Disease Treatments Revenue by Country (2023-2028) & (USD Million)
Table 93. Middle East & Africa Parkinson's Disease Treatments Revenue by Type (2017-2022) & (USD Million)
Table 94. Middle East & Africa Parkinson's Disease Treatments Revenue by Type (2023-2028) & (USD Million)
Table 95. Middle East & Africa Parkinson's Disease Treatments Revenue by Application (2017-2022) & (USD Million)
Table 96. Middle East & Africa Parkinson's Disease Treatments Revenue by Application (2023-2028) & (USD Million)
Table 97. Middle East & Africa Parkinson's Disease Treatments Revenue by Country (2017-2022) & (USD Million)
Table 98. Middle East & Africa Parkinson's Disease Treatments Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Parkinson's Disease Treatments Picture
Figure 2. Global Parkinson's Disease Treatments Revenue Market Share by Type in 2021
Figure 3. Dopamine Agonists
Figure 4. Levodopa
Figure 5. Glutamate Antagonist
Figure 6. Apomorphine
Figure 7. COMT Inhibitors Anticholinergics
Figure 8. MAO-B Inhibitors
Figure 9. Other Drugs
Figure 10. Parkinson's Disease Treatments Revenue Market Share by Application in 2021
Figure 11. Hospitals Picture
Figure 12. Healthcare Institutes Picture
Figure 13. Others Picture
Figure 14. Global Parkinson's Disease Treatments Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 15. Global Parkinson's Disease Treatments Revenue and Forecast (2017-2028) & (USD Million)
Figure 16. Global Parkinson's Disease Treatments Revenue Market Share by Region (2017-2028)
Figure 17. Global Parkinson's Disease Treatments Revenue Market Share by Region in 2021
Figure 18. North America Parkinson's Disease Treatments Revenue (USD Million) and Growth Rate (2017-2028)
Figure 19. Europe Parkinson's Disease Treatments Revenue (USD Million) and Growth Rate (2017-2028)
Figure 20. Asia-Pacific Parkinson's Disease Treatments Revenue (USD Million) and Growth Rate (2017-2028)
Figure 21. South America Parkinson's Disease Treatments Revenue (USD Million) and Growth Rate (2017-2028)
Figure 22. Middle East and Africa Parkinson's Disease Treatments Revenue (USD Million) and Growth Rate (2017-2028)
Figure 23. Parkinson's Disease Treatments Market Drivers
Figure 24. Parkinson's Disease Treatments Market Restraints
Figure 25. Parkinson's Disease Treatments Market Trends
Figure 26. GSK Recent Developments and Future Plans
Figure 27. Merck Recent Developments and Future Plans
Figure 28. Novartis Recent Developments and Future Plans
Figure 29. Teva Recent Developments and Future Plans
Figure 30. Boehringer Ingelheim Recent Developments and Future Plans
Figure 31. Impax Recent Developments and Future Plans
Figure 32. Abbvie Recent Developments and Future Plans
Figure 33. Bausch Health Recent Developments and Future Plans
Figure 34. Lundbeck Recent Developments and Future Plans
Figure 35. Sun Pharma Recent Developments and Future Plans
Figure 36. Wockhardt Recent Developments and Future Plans
Figure 37. Acadia Recent Developments and Future Plans
Figure 38. UCB Recent Developments and Future Plans
Figure 39. Global Parkinson's Disease Treatments Revenue Share by Players in 2021
Figure 40. Parkinson's Disease Treatments Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 41. Global Top 3 Players Parkinson's Disease Treatments Revenue Market Share in 2021
Figure 42. Global Top 10 Players Parkinson's Disease Treatments Revenue Market Share in 2021
Figure 43. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 44. Global Parkinson's Disease Treatments Revenue Share by Type in 2021
Figure 45. Global Parkinson's Disease Treatments Market Share Forecast by Type (2023-2028)
Figure 46. Global Parkinson's Disease Treatments Revenue Share by Application in 2021
Figure 47. Global Parkinson's Disease Treatments Market Share Forecast by Application (2023-2028)
Figure 48. North America Parkinson's Disease Treatments Sales Market Share by Type (2017-2028)
Figure 49. North America Parkinson's Disease Treatments Sales Market Share by Application (2017-2028)
Figure 50. North America Parkinson's Disease Treatments Revenue Market Share by Country (2017-2028)
Figure 51. United States Parkinson's Disease Treatments Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Canada Parkinson's Disease Treatments Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Mexico Parkinson's Disease Treatments Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Europe Parkinson's Disease Treatments Sales Market Share by Type (2017-2028)
Figure 55. Europe Parkinson's Disease Treatments Sales Market Share by Application (2017-2028)
Figure 56. Europe Parkinson's Disease Treatments Revenue Market Share by Country (2017-2028)
Figure 57. Germany Parkinson's Disease Treatments Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. France Parkinson's Disease Treatments Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. United Kingdom Parkinson's Disease Treatments Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Russia Parkinson's Disease Treatments Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Italy Parkinson's Disease Treatments Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Asia-Pacific Parkinson's Disease Treatments Sales Market Share by Type (2017-2028)
Figure 63. Asia-Pacific Parkinson's Disease Treatments Sales Market Share by Application (2017-2028)
Figure 64. Asia-Pacific Parkinson's Disease Treatments Revenue Market Share by Region (2017-2028)
Figure 65. China Parkinson's Disease Treatments Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Japan Parkinson's Disease Treatments Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. South Korea Parkinson's Disease Treatments Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. India Parkinson's Disease Treatments Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Southeast Asia Parkinson's Disease Treatments Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Australia Parkinson's Disease Treatments Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. South America Parkinson's Disease Treatments Sales Market Share by Type (2017-2028)
Figure 72. South America Parkinson's Disease Treatments Sales Market Share by Application (2017-2028)
Figure 73. South America Parkinson's Disease Treatments Revenue Market Share by Country (2017-2028)
Figure 74. Brazil Parkinson's Disease Treatments Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Argentina Parkinson's Disease Treatments Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Middle East and Africa Parkinson's Disease Treatments Sales Market Share by Type (2017-2028)
Figure 77. Middle East and Africa Parkinson's Disease Treatments Sales Market Share by Application (2017-2028)
Figure 78. Middle East and Africa Parkinson's Disease Treatments Revenue Market Share by Country (2017-2028)
Figure 79. Turkey Parkinson's Disease Treatments Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 80. Saudi Arabia Parkinson's Disease Treatments Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 81. UAE Parkinson's Disease Treatments Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 82. Methodology
Figure 83. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
